Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.595 USD | +1.59% | -3.05% | +8.16% |
May. 15 | Earnings Flash (SPRO) SPERO THERAPEUTICS Reports Q1 Revenue $9.3M | MT |
Mar. 13 | Transcript : Spero Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.16% | 84.61M | |
+8.59% | 114B | |
+10.80% | 104B | |
-12.90% | 22.41B | |
-1.19% | 22.28B | |
-5.24% | 19.07B | |
-38.29% | 18B | |
-5.05% | 17.89B | |
+7.57% | 14.28B | |
+35.84% | 12.55B |
- Stock Market
- Equities
- SPRO Stock
- News Spero Therapeutics, Inc.
- Insider Trends: Insider Prolongs Selling Trend at Spero Therapeutics